This is consistent with earlier work which shows that ataxin-2 knockdown can suppress toxicity in yeast, Drosophila and mouse models of C9orf72-FTD/ALS (Elden et al., 2010; Becker et al., 2017). This evidence concerns the gene C9orf72 and frontotemporal dementia.